Global Allergy Diagnostics Market Size, Share, Production, Growth, Trends, and Forecast 2019-2026

The global allergy diagnostics market is likely to expand at a 12.80% CAGR over the forecast period 2019 to 2026. At this rate, the market is estimated to be worth US$4.7 bn by 2026. Among the product types, consumable are projected to gain prominence in the global allergy diagnostics market. Geography-wise, North America is anticipated to remain a lucrative regional market over the forecast period. This could be on account on the first-class healthcare infrastructure in the region.

The global allergy diagnostics market is categorized on the basis of segments such as product type, allergen type, test type, and end-users. Out of various types of tests, the in-vivo test segment is likely to dominate the allergy diagnostics market globally. The growth is attributed to the benefits such as affordability, hassle-free procedures, and higher efficiency. Also, the lower cost involved in the test is one of the major factors that brings in-vivo test segment at the leader's spot in the global allergy diagnostics market.

North America shall emerge as the leading region in the allergy diagnostics market. This is attributed to factors such as superior healthcare infrastructure and growing awareness of the people regarding allergy treatment in countries like U.S and Canada. The report suggests that the region is also experiencing growth owing to developments such as investment of cutting-edge technology and research taking place in various countries of the region. Also, various initiatives to offer better allergy treatment to the patients are also promoting the region in allergy diagnostics market.

Surge in Incidence of Allergies to Spur Growth

Patients are required to be diagnosed with allergies such as hay fever accurately. Food allergies are also increasing. There are about 17 million EU citizens with food allergies, and in the last ten years hospital admissions for severe allergies and their reactions have increased seven times in children, according to the European Academy of Allergy and Clinical Immunology (EAACI). Anaphylaxis, nutritional allergies, forms of asthma, conjunctivitis, eczema, eosine and allergy to medicinal products and insects include allergy. The new diagnostic market is therefore expected to grow at a good pace with the increasing incidence of allergic diseases. Additionally, the emerging strategies for detection and control through new approaches for allergies are expected to drive the allergy diagnostics market in the coming years.

Spread of Awareness Regarding Allergens to Boost Opportunity

Governments worldwide are gradually encouraging the expansion of vaccines and new treatments for different allergic syndromes, thereby fueling the expansion of the market for allergy diagnostics. Governments also invest in research and development activities to expand high-tech diagnostic methods for allergic diseases. As governments take actions to improve health care facilities, the main contributors to the development of the health sector are major drug companies and medicines for allergic syndromes.

The global allergy diagnostics market is expected to see high growth in the coming years. The market's competitive landscape comprises features consolidation at present, with a small number of vendors holding substantial shares in the global allergy diagnostics market. The market fosters moderate competition among the vendors.

Market players are seen focusing on several organic and inorganic strategies in order to gain momentum in the global allergy diagnostics market. Among these, mergers and acquisitions, and partnerships are expected to be adopted gratuitously. Vendors are furthers seen focusing on adopting the latest technological innovations in their offering. Research and development of novel products is another area that players are focusing on in order to gain market shares.

The players that influence the growth of global allergy diagnostics market are Omega Diagnostics Group Plc., Satllergenes Geer, Quest Diagnostics Inc., and BioMeriux. These players are investing heavily in research and development in order to provide the best diagnosis for new allergens that are affecting people's health today.

Growing Cases of Dust Induced Allergies to Boost the Market Growth

There are many factors that can trigger allergy in any human or animal. This makes it crucial for various offices, hospitals, and factories to have a quick and hassle-free anti-allergic mechanism. It is because of these factors that the global allergy diagnostics market is likely to have robust growth in the forecast period.

To treat an allergy, it is extremely important for doctors to understand the very root of the allergy. This is where allergy diagnostic centers come into the play, as they provide a detailed report about the type, cause, criticality of the allergy for the patients. This, in turn, results in the growth of global allergy diagnostics market. Medical practitioners have proven that allergies can be the cause of various several other chronic diseases, and there is a dire need to find a robust anti-allergic mechanism for allergic patients. This is also a crucial factor that is accelerating the growth of the global allergy diagnostics market in the forecast period.

Growing Health Awareness to Offer Ample Opportunity to Businesses

Various health awareness initiatives taken by various commercial and non-commercial organizations across the globe shall allow the businesses in the market to gain substantial profit during the forecast period. Although, the growth of the global allergy diagnostics market may lose its momentum as a result of higher cost involved in various tests and related products. Nevertheless, the constant research and development in allergy diagnosis methods and constant launch of new products by various players, will keep the growth intact in the global allergy diagnostics market during the forecast period.

The competitive landscape of global allergy diagnostics market is the portrayal of intense competition. This is because of people across the globe who have the tendency to be allergic to some or the other thing. Nevertheless, businesses in the global allergy diagnostics market thrive on such opportunities. In order to stay ahead of their competitors, market players in allergy diagnostic market are getting involved in activities such as mergers and partnerships, collaborations, and even acquisitions of various small- and medium-scale businesses. These strategies allow the businesses to capture maximum opportunities offered by the global allergy diagnostics market.

The global allergy diagnostics market has been segmented as follows:

Global Allergy Diagnostics Market, by Product

  • Assay Kits
  • Consumables
  • Instruments

Global Allergy Diagnostics Market, by Allergen Type

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Others

Global Allergy Diagnostics Market, by Tests

  • In-vivo tests
  • In-vitro tests

Global Allergy Diagnostics Market, by End-users

  • Hospitals
  • Diagnostic Laboratories
  • Academic Research Institutes
  • Others

Global Allergy Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Allergy Diagnostics: Market Snapshot
3.2 Global Market Share Analysis by Region, 2015
3.3 Global Allergy Diagnostics Market: Opportunity Map

Section 4 Market Overview
4.1 Product Overview
4.2 Global Allergy Diagnostics Market: Key Industry Developments
4.3 Global Allergy Diagnostics Market: Market Indicators

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
     5.2.1 Hygiene Hypothesis
     5.2.2 Climatic Changes
     5.2.3 Increasing prevalence of allergies
     5.2.4 Advanced technologies for allergy diagnostics
     5.2.5 Genetic Factors responsible for allergies
     5.2.6 Increased healthcare expenditure worldwide
     5.2.8 Rising per capita healthcare expenditure
5.3 Restraints
     5.3.1 Standardization in quality of allergen extracts
     5.3.2 Difficulty in quality control of test results
5.4 Opportunities
     5.4.1 Genetics and Epigenetics in Allergy
     5.4.2 Molecular Approach to Allergy Diagnostics
5.5 Porters Analysis
5.6 Value Chain Analysis
5.7 Allergy Diagnostics Market Outlook

Section 6 Allergy Diagnostics Market Analysis, by Product Type
6.1 Key Findings
6.2 Introduction
6.3 Global Allergy Diagnostics Market Value Share Analysis, by Product Type 
6.4 Allergy Diagnostics Market Forecast, by Product Type 
6.5 Allergy Diagnostics Market Analysis, by Product Type 
     6.5.1 Assay Kits 
     6.5.2 Consumables
     6.5.3 Instruments
6.6 Allergy Diagnostics Market Attractiveness Analysis, by Product Type 
6.7 Key Trends

Section 7 Allergy Diagnostics Market Analysis, by Allergen Type
7.1 Key Findings
7.2 Introduction
7.3 Global Allergy Diagnostics Market Value Share Analysis, by Allergen Type
7.4 Allergy Diagnostics Market Forecast, by Allergen Type 
7.5 Allergy Diagnostics Market Analysis, by Allergen Type 
     7.5.1 Inhaled Allergens
     7.5.2 Food Allergens
     7.5.3 Drug Allergens
     7.5.4 Others
7.6 Allergy Diagnostics Market Attractiveness Analysis, by Allergen Type 
7.7 Key Trends

Section 8 Allergy Diagnostics Market Analysis, by Tests
8.1 Key Findings
8.2 Introduction
8.3 Global Allergy Diagnostics Market Value Share Analysis, by tests
8.4 Allergy Diagnostics Market Forecast, by Tests
8.5 Allergy Diagnostics Market Analysis, by Tests 
     8.5.1 In-vivo tests
     8.5.2 In-vitro tests
8.6 Allergy Diagnostics Market Attractiveness Analysis, by Tests
8.7 Key Trends

Section 9 Allergy Diagnostics Market Analysis, by End Users
9.1 Key Findings
9.2 Introduction
9.3 Global Allergy Diagnostics Market Value Share Analysis, by End Users
9.4 Allergy Diagnostics Market Forecast, by End Users
9.5 Allergy Diagnostics Market Analysis, by End Users
     9.5.1 Hospitals 
     9.5.2 Diagnostic Laboratories
     9.5.3 Academic Research Institutes
     9.5.4 Others
9.6 Allergy Diagnostics Market Attractiveness Analysis, by End Users

Section 10 Allergy Diagnostics Market Analysis, by Region
10.1 Global Allergy Diagnostics Market Snapshot, by Country
10.2 Global Allergy Diagnostics Market Value Share Analysis, by Region
10.3 Allergy Diagnostics Market Forecast, by Region
10.4 Market Attractiveness Analysis, by Region

Section 11 North America Allergy Diagnostics Market Analysis
11.1 Key Findings
11.2 Market Overview
11.3 Market Analysis, By Country
     11.3.1 North America Market Value Share Analysis, By Country
     11.3.2 North America Market Forecast by Country
11.4 Market Analysis, By Product
     11.4.1 North America Market Value Share Analysis, By Product Type
     11.4.2 North America Market Forecast, By Product Type
11.5 Market Analysis, By Allergen Type
     11.5.1 North America Market Value Share Analysis, By Allergen Type
     11.5.2 North America Market Forecast, By Allergen Type
11.6 Market Analysis, By Tests 
     11.6.1 North America Market Value Share Analysis, By Tests
     11.6.2 North America Market Forecast, By Tests
11.7 Market Analysis, By End-users
     11.7.1 North America Market Value Share Analysis, By End-users 
     11.7.2 North America Market Forecast, By End-users 
11.8 North America Market Attractiveness Analysis
     11.8.1 by Product Type
     11.8.2 by Allergen Type
     11.8.3 by Tests
     11.8.4 by End-users
11.9 Market Trends

Section 12 Europe Allergy Diagnostics Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Market Analysis, By Country
     12.3.1 Europe Market Value Share Analysis, By Country
     12.3.2 Europe Market Forecast, By Country
12.4 Market Analysis, By Product
     12.4.1 Europe Market Value Share Analysis, By Product Type
     12.4.2 Europe Market Forecast, By Product Type
12.5 Market Analysis, By Allergen Type
     12.5.1 Europe Market Value Share Analysis, By Allergen Type
     12.5.2 Europe Market Forecast, By Allergen Type
12.6 Market Analysis, By Tests
     12.6.1 Europe Market Value Share Analysis, By Tests
     12.6.2 Europe Market Forecast, By Tests
12.7 Market Analysis, By End-users
     12.7.1 Europe Market Value Share Analysis, By End-users 
     12.7.2 Europe Market Forecast, By End-users 
12.8 Europe Market Attractiveness Analysis
     12.8.1 by Product
     12.8.2 by Allergen Type
     12.8.3 by Tests
     12.8.4 by End-users 
12.9 Market Trends

Section 13 Asia Pacific Allergy Diagnostics Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Market Analysis, By Country
     13.3.1 Asia Pacific Market Value Share Analysis, By Country
     13.3.2 Asia Pacific Market Forecast, By Country
13.4 Market Analysis, By Product
     13.4.1 Asia Pacific Market Value Share Analysis, By Product Type
     13.4.2 Asia Pacific Market Forecast, By Product Type
13.5 Market Analysis, By Allergen Type
     13.5.1 Asia Pacific Market Value Share Analysis, By Allergen Type
     13.5.2 Asia Pacific Market Forecast, By Allergen Type
13.6 Market Analysis, By Tests
     13.6.1 Asia Pacific Market Value Share Analysis, By Tests
     13.6.2 Asia Pacific Market Forecast, By Tests
13.7 Market Analysis, By End-users
     13.7.1 Asia Pacific Market Value Share Analysis, By End-users 
     13.7.2 Asia Pacific Market Forecast, By End-users 
13.8 Asia Pacific Market Attractiveness Analysis
     13.8.1 by Product
     13.8.2 by Allergen Type
     13.8.3 by Tests
     13.8.4 by End-users 
13.9 Market Trends

Section 14 Latin America Allergy Diagnostics Market Analysis
14.1 Key Findings
14.2 Market Overview
14.3 Market Analysis, By Country
     14.3.1 Latin America Market Value Share Analysis, By Country
     14.3.2 Latin America Market Forecast, By Country
14.4 Market Analysis, By Product
     14.4.1 Latin America Market Value Share Analysis, By Product Type
     14.4.2 Latin America Market Forecast, By Product Type
14.5 Market Analysis, By Allergen Type
     14.5.1 Latin America Market Value Share Analysis, By Allergen Type
     14.5.2 Latin America Market Forecast, By Allergen Type
14.6 Market Analysis, By Tests
     14.6.1 Latin America Market Value Share Analysis, By Tests
     14.6.2 Latin America Market Forecast, By Tests
14.7 Market Analysis, By End-users
     14.7.1 Latin America Market Value Share Analysis, By End-users 
     14.7.2 Latin America Market Forecast, By End-users 
14.8 Latin America Market Attractiveness Analysis
     14.8.1 by Product
     14.8.2 by Allergen Type
     14.8.3 by Tests
     14.8.4 by End-users 
14.9 Market Trends

Section 15 Middle East & Africa Allergy Diagnostics Market Analysis
15.1 Key Findings
15.2 Market Overview
15.3 Market Analysis, By Country
     15.3.1 MEA Market Value Share Analysis, By Country
     15.3.2 MEA Market Forecast, By Country
15.4 Market Analysis, By Product
     15.4.1 MEA Market Value Share Analysis, By Product Type
     15.4.2 MEA Market Forecast, By Product Type
15.5 Market Analysis, By Allergen Type
     15.5.1 MEA Market Value Share Analysis, By Allergen Type
     15.5.2 MEA Market Forecast, By Allergen Type
15.6 Market Analysis, By Tests
     15.6.1 MEA Market Value Share Analysis, By Tests
     15.6.2 MEA Market Forecast, By Tests
15.7 Market Analysis, By End-users
     15.7.1 MEA Market Value Share Analysis, By End-users 
     15.7.2 MEA Market Forecast, By End-users 
15.8 MEA Market Attractiveness Analysis
     15.8.1 by Product
     15.8.2 by Allergen Type
     15.8.3 by Tests
     15.8.4 by End-users 
15.9 Market Trends

Section 16 Company Profiles
16.1 Global Allergy Diagnostics Market Share Analysis, By Company (2015)
16.2 Competition Matrix
16.3 Company Profiles
     16.3.1 Thermo Fischer Scientific, Inc.
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.2 Quest Diagnostics, Inc.
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.3 Stallergenes Greer
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.4 BioMerieux SA
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.5 Omega Diagnostics Group Plc.
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.6 Siemens Healthineers
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.7 HAL Allergy Group
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.8 Lincoln Diagnostics, Inc.
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview
     16.3.9 Hitachi Chemical Diagnostics, Inc.
              16.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
              16.3.1.2 Financial Overview
              16.3.1.3 Product Portfolio
              16.3.1.4 SWOT Analysis
              16.3.1.5 Strategic Overview

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers